{"id":"W2160457008","doi":"10.1111/j.1365-2141.2009.07881.x","title":"Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Pyrogenesis (Canada); Princess Margaret Cancer Centre; Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"National Cancer Institute; D. Warren Brown Family Foundation; Leukemia and Lymphoma Society","keywords":"Fludarabine; Medicine; Chronic lymphocytic leukemia; Rituximab; Internal medicine; Concomitant; Histone deacetylase inhibitor; Histone deacetylase; Tolerability; Gastroenterology; Pharmacokinetics; Toxicity; Refractory (planetary science); Oncology; Pharmacology; Lymphoma; Leukemia; Chemotherapy; Adverse effect; Histone; Biology; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009141759,0.000895262,0.001945355,0.0002986108,0.0003798954,0.0007509592,0.0006557375,0.0008520059,0.001901535],"category_scores_gemma":[0.0005966807,0.0004206498,0.0006576731,0.0004338632,0.0008340743,0.0003896033,0.0003230781,0.001795157,0.000588043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008276185,"about_ca_system_score_gemma":0.001327781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001496529,"about_ca_topic_score_gemma":0.002863716,"domain_scores_codex":[0.9997538,0.00009703963,0.0000124069,0.00004449706,0.00002509566,0.00006716318],"domain_scores_gemma":[0.9995264,0.00006488131,0.00006275297,0.00003662013,0.00002196958,0.0002874269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4708884,0.09418982,0.03593224,0.0007849797,0.001279414,0.00104224,0.0006826463,0.004090426,0.1328687,0.0004610986,0.00542062,0.2523594],"study_design_scores_gemma":[0.310596,0.6353697,0.03733207,0.00003844882,0.0003825455,0.0007982205,0.00009642832,0.001846148,0.007216963,0.0002066355,0.00608553,0.00003146609],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941024,0.00255332,0.0004817706,0.0002819664,0.00007973435,0.001099644,0.0003500845,0.00009097972,0.0009600429],"genre_scores_gemma":[0.9919608,0.001802748,0.001265071,0.000749999,0.0001256601,0.001396975,0.001252025,0.00002258906,0.001424134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001945355,"threshold_uncertainty_score":0.006361246,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009130678814489193,"score_gpt":0.2905438412582437,"score_spread":0.2814131624437545,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}